These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4571653)

  • 1. Growth of Hansenula holstii on cadavers.
    Kurtzman CP; Gentles JC; Evans EG; Slodki ME; Ward RM
    Appl Microbiol; 1973 Feb; 25(2):184-6. PubMed ID: 4571653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Henna: the cosmetic antimycotic drug].
    Itani ZS
    Hautarzt; 1973 Feb; 24(2):83-5. PubMed ID: 4570883
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole.
    Hoeprich PD; Merry JM
    J Clin Microbiol; 1986 Aug; 24(2):269-71. PubMed ID: 3528213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial agents. XXI. Dependence of antifungal activity on the structure of the side chain in the pyrimidine group.
    Capek A; Simek A; Brůna L; Sváb A; Budĕsínský Z
    Folia Microbiol (Praha); 1974; 19(2):169-71. PubMed ID: 4611876
    [No Abstract]   [Full Text] [Related]  

  • 5. Polyoxin D inhibits growth of zoopathogenic fungi.
    Becker JM; Covert NL; Shenbagamurthi P; Steinfeld AS; Naider F
    Antimicrob Agents Chemother; 1983 Jun; 23(6):926-9. PubMed ID: 6351734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal effects of vitamin K3 on Cryptococcus neoformans and Candida albicans.
    Jen TM
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 Aug; 15(3):250-2. PubMed ID: 6754288
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of asperginon--new pigment metabolite of Aspergillus sp].
    Sokolov LB; Alekseeva LA; Ivanova NV; Kul'bakh VO; Kuznetsova NA
    Antibiotiki; 1972 Aug; 17(8):745-50. PubMed ID: 4564363
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B.
    Anaissie E; Paetznick V; Proffitt R; Adler-Moore J; Bodey GP
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):665-8. PubMed ID: 1748123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "In vitro" antimycotic activity of fenticonazole (Rec 15/1476).
    Costa AL
    Mykosen; 1982 Jan; 25(1):47-52. PubMed ID: 7040949
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of antifungal antibiotics on some determinants of virulence in Candida albicans and Cryptococcus neoformans cells.
    Borowski J; Jakoniuk P; Jablońska W; Jakubicz W; Szpak A
    Experientia; 1974 Oct; 30(10):1210-1. PubMed ID: 4611784
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of bongkrekic acid on growth and metabolism of filamentous fungi.
    Subík J; Behún M
    Arch Mikrobiol; 1974 Apr; 97(1):81-8. PubMed ID: 4857952
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro antifungal and antibiofilm activities of halogenated quinoline analogues against Candida albicans and Cryptococcus neoformans.
    Zuo R; Garrison AT; Basak A; Zhang P; Huigens RW; Ding Y
    Int J Antimicrob Agents; 2016 Aug; 48(2):208-11. PubMed ID: 27256584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.
    Al Jalali V; Sauermann R; Eberl S; Zeitlinger M
    Infection; 2019 Aug; 47(4):565-570. PubMed ID: 30725316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Moronal sensitivity of 590 yeasts and yeast-like fungi from fecal specimen of patients with gastrointestinal disturbances].
    Abou-Gabal M; Zoric V
    Mykosen; 1969 Jan; 12(1):77-80. PubMed ID: 5407929
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-microbial and anti-biofilm activities of combined chelerythrine-sanguinarine and mode of action against Candida albicans and Cryptococcus neoformans in vitro.
    Qian W; Yang M; Li X; Sun Z; Li Y; Wang X; Wang T
    Colloids Surf B Biointerfaces; 2020 Jul; 191():111003. PubMed ID: 32276211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fungostatic activity in vitro of the new antibiotic--pimaricin (natamycin)].
    Porebska A; Laskownicka Z; Zemburowa K
    Med Dosw Mikrobiol; 1971; 23(1):71-6. PubMed ID: 5314225
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro antifungal activities of Bay n 7133 and Bay L 9139, two new orally absorbed antifungal imidazole derivatives, against pathogenic yeasts.
    Fromtling RA; Yu HP; Shadomy S
    Mycopathologia; 1984 Apr; 86(1):45-50. PubMed ID: 6330557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility and resistance of Candida spp. to hamycin.
    Athar MA
    Sabouraudia; 1971 Nov; 9(3):256-62. PubMed ID: 4944203
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of formalin on the survival of systemic fungi in tissue.
    Fahmy A; Flournoy DJ; Stewart CV
    Mycopathologia; 1983 Jun; 82(3):175-8. PubMed ID: 6350884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inhibitors of cholesterol biosynthesis on yeast growth.
    Gallo DG; Zygmunt WA
    Proc Soc Exp Biol Med; 1970 Mar; 133(3):862-4. PubMed ID: 5309330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.